P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
Public ClinicalTrials.gov record NCT04960579. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label, Multicenter, Phase 1 Study to Assess the Safety of P-BCMA-ALLO1 in Subjects With Relapsed / Refractory Multiple Myeloma (MM)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 1 study comprised of open-label, dose escalation, multiple cohorts of P-BCMA-ALLO1 allogeneic T stem cell memory (Tscm) CAR-T cells in subjects with relapsed / refractory Multiple Myeloma (RRMM).
Study identification
- NCT ID
- NCT04960579
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 275 participants
Conditions and interventions
Conditions
Interventions
- P-BCMA-ALLO1 CAR-T cells Biological
- Rimiducid Drug
- Methotrexate Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 5, 2022 (Actual)
- Primary completion
- Mar 2029 (Estimated)
- Completion
- Mar 2042 (Estimated)
- Last update posted
- Apr 24, 2026
2022 – 2042
United States locations
- U.S. sites
- 23
- U.S. states
- 16
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope | Goodyear | Arizona | 85338 | — |
| University of California San Diego | San Diego | California | 92093 | — |
| University of California San Francisco | San Francisco | California | 94143 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Blood Marrow and Transplant Group of Georgia | Atlanta | Georgia | 30342 | — |
| City of Hope | Chicago | Illinois | 60099 | — |
| Advocate Aurora Health | Park Ridge | Illinois | 66068 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| University of Maryland Greenebaum Comprehensive Cancer Center | Baltimore | Maryland | 21201 | — |
| Wayne State - Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Hackensack Meridian Health | Hackensack | New Jersey | 07601 | — |
| Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14263 | — |
| Mount Sinai | New York | New York | 10029 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599-1350 | — |
| University of Cincinnati | Cincinnati | Ohio | 45221 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| University of Oklahoma, Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104-4238 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Sarah Cannon Research Institute - St. David's South Austin Medical Center | Austin | Texas | 78704 | — |
| Houston Methodist Research Institute | Houston | Texas | 77030 | — |
| Sarah Cannon Research Institute - Methodist Healthcare | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04960579, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 24, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04960579 live on ClinicalTrials.gov.